P459: DISEASE MONITORING OF NPM1-MUTANT (MUT) ACUTE MYELOID LEUKEMIA (AML) USING MEASURABLE RESIDUAL DISEASE (MRD) ASSESSMENTS DURING ORAL AZACITIDINE (ORAL-AZA) TREATMENT (TX): A QUAZAR AML-001 SUBANALYSIS

oleh: Daniel Lopes De Menezes, Gail Roboz, Hartmut Döhner, Andrew Wei, Maria Teresa Voso, Andre Schuh, Wendy L. See, Manuel Ugidos, Arnaud Amzallag, Alberto Risueño, Kevin H. Eng, Rajasekhar Nvs Suragani, Barry Skikne, CL Beach, Thomas Prebet, Anita Gandhi